Therapeutic Challenges in Neuroendocrine Tumors

被引：4
|
作者：
Legakis, Ioannis [1 ]
Saif, Muhammad Wasif [2 ]
Syrigos, Konstantinos [1 ]
机构：
[1] Athens Sch Med, Sotiria Gen Hosp, Dept Internal Med 3, Oncol Unit, Athens, Greece
[2] Tufts Univ, Dept Hematol Oncol, Med Ctr, Boston, MA 02111 USA
来源：
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 2017年 / 17卷 / 07期
关键词：
Neuroendocrine tumors; biomarkers; somatostatin analogs; angiogenesis inhibitors; cytotoxic chemotherapy; radionuclide therapy; liver-targeted therapies; RECEPTOR RADIONUCLIDE THERAPY; PLASMA CHROMOGRANIN-A; ISLET-CELL TUMORS; LIVER-METASTASES; PHASE-II; GEP-NETS; SOMATOSTATIN ANALOGS; ENDOCRINE TUMORS; DIAGNOSIS; SURVIVAL;
D O I：
10.2174/1871520617666170213113401
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Neuroendocrine tumors (NETs) are a diverse set of tumors, being genetically varied. NETs can be presented with a distinct clinical picture, due to the production of various hormones, or being silent. Based on community health clinical statistics, the frequency numbers and reported occurrence of NETs are increasing. Although the therapeutic options for NETs have expanded in recent years, clinical diagnosis is possible only when metastases are present, requiring chronic complicated medical management. A positive development is that the recent evolution of molecularly-targeted therapy in oncology promotes the evolution of innovative tools for the management of these tumors. A diverse assortment of medical specialists is needed to improve outcomes and orchestrate the therapeutic care plan for NET patients.
引用
收藏
页码：902 / 919
页数：18
相关论文
共 50 条
  • [31] Therapeutic Challenges for Gastric Neuroendocrine Neoplasms: Take It or Leave It?
    Cavalcoli, Federica
    Gallo, Camilla
    Coltro, Lorenzo Andrea
    Rausa, Emanuele
    Cantu, Paolo
    Invernizzi, Pietro
    Massironi, Sara
    MEDICINA-LITHUANIA, 2023, 59 (10):
  • [32] Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system
    Pellat, Anna
    Wislez, Marie
    Svrcek, Magali
    Hammel, Pascal
    Afchain, Pauline
    Andre, Thierry
    BULLETIN DU CANCER, 2016, 103 (10) : 880 - 895
  • [33] Neuroendocrine Tumors Committee of Reference Hospital: Decision-Making Process on the Diagnostic and Therapeutic Approach to Patients with Neuroendocrine Tumors
    Jimenez-Fonseca, P.
    Valdes, N.
    Fernandez del Valle, A.
    Miguel, C.
    Lauret, M. E.
    Perez, G.
    Avello, N.
    Turienzo, E.
    Arguelles, B.
    Fernandez Llana, B.
    Vega, F.
    Menendez, E.
    NEUROENDOCRINOLOGY, 2018, 106 : 90 - 90
  • [34] Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges
    Refardt, Julie
    Hofland, Johannes
    Kwadwo, Antwi
    Nicolas, Guillaume P.
    Rottendurger, Christof
    Fani, Melpomeni
    Wild, Damian
    Christ, Emanuel
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2021, 22 (03): : 581 - 594
  • [35] Theranostics in neuroendocrine tumors: an overview of current approaches and future challenges
    Julie Refardt
    Johannes Hofland
    Antwi Kwadwo
    Guillaume P. Nicolas
    Christof Rottenburger
    Melpomeni Fani
    Damian Wild
    Emanuel Christ
    Reviews in Endocrine and Metabolic Disorders, 2021, 22 : 581 - 594
  • [36] Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix
    Eric K. Nakakura
    Annals of Surgical Oncology, 2018, 25 : 591 - 593
  • [37] Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix
    Nakakura, Eric K.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (03) : 591 - 593
  • [38] Differential Signalling Pathways Drive Therapeutic Resistance in Neuroendocrine Tumors
    Romano, D.
    Gerard, C.
    Poizat, F.
    Niccoli, P.
    Barlier, A.
    NEUROENDOCRINOLOGY, 2018, 106 : 16 - 16
  • [39] Identification of Tumorigenic Cells and Therapeutic Targets in Pancreatic Neuroendocrine Tumors
    Krampitz, G. W.
    George, B. M.
    Willingham, S. B.
    Volkmer, J. P.
    Weiskopf, K. A.
    Jahchan, N. S.
    Newman, A. M.
    Sahoo, D.
    Zemek, A.
    Yanovsky, R. L.
    Nguyen, J. K.
    Schnorr, P. J.
    Mazur, P. K.
    Sage, J.
    Longacre, T. A.
    Norton, J. A.
    Weissman, I. L.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S99 - S99
  • [40] Neuroendocrine tumors of the gastroenteropancreatic system .2. Therapeutic advances
    Scherubl, H
    Buhr, H
    Faiss, S
    Zimmer, T
    Riecken, EO
    Wiedenmann, B
    ONKOLOGIE, 1996, 19 (03): : 214 - 219
12345